|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.900 CNY | +1.14% |
|
-0.78% | -15.88% |
| Market Cap | 4.4B 652M 566M 529M 485M 915M 62.11B 931M 6.23B 2.44B 30.97B 2.45B 2.39B 102B | P/E 2024 |
-50.1x | P/E 2025 | 353x |
|---|---|---|---|---|---|
| Enterprise Value | 2.86B 423M 368M 344M 315M 595M 40.35B 605M 4.05B 1.59B 20.12B 1.59B 1.55B 66.37B | EV / Sales 2024 |
4.33x | EV / Sales 2025 | 8.78x |
| Free-Float |
42.82% | Yield 2024 * |
-
| Yield 2025 | 2.84% |
| 1 day | +1.14% | ||
| 1 week | -0.78% | ||
| Current month | +1.14% | ||
| 1 month | -10.64% | ||
| 3 months | -18.42% | ||
| 6 months | -19.38% | ||
| Current year | -15.88% |
| 1 week | 8.48 |  | 8.97 |
| 1 month | 8.35 | | 10.66 |
| Current year | 7.77 | | 12.9 |
| 1 year | 7.77 | | 16.25 |
| 3 years | 5.73 | | 17.49 |
| 5 years | 5.73 | | 18.75 |
| 10 years | 5.73 | | 28.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Biao Ma
CEO | Chief Executive Officer | 62 | 2001-07-04 |
Dong Na Liang
DFI | Director of Finance/CFO | 45 | 2024-01-25 |
Li Ma
DFI | Director of Finance/CFO | 57 | 2006-12-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Wang
BRD | Director/Board Member | 48 | 2009-02-28 |
Biao Ma
CHM | Chairman | 62 | 2001-07-04 |
Li Ma
BRD | Director/Board Member | 57 | 2005-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.14% | -0.78% | -39.70% | -18.05% | 635M | |
| +0.60% | -7.38% | +47.02% | +151.53% | 1T | |
| -0.71% | -5.20% | +47.84% | +49.59% | 613B | |
| +0.16% | -6.44% | +24.88% | +66.70% | 433B | |
| +0.97% | -2.17% | +41.14% | +35.79% | 350B | |
| +0.25% | -4.08% | +32.25% | +40.43% | 292B | |
| +1.56% | -9.61% | +5.03% | +7.20% | 239B | |
| +2.02% | -8.05% | -1.47% | -41.90% | 206B | |
| +1.03% | -2.42% | +27.04% | +57.67% | 204B | |
| +0.16% | -2.32% | +14.58% | +66.76% | 163B | |
| Average | +0.69% | -3.45% | +19.86% | +41.57% | 350.11B | |
| Weighted average by Cap. | +0.43% | -4.34% | +34.19% | +71.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 416M 61.65M 53.58M 50.02M 45.92M 86.58M 5.88B 88.09M 590M 231M 2.93B 232M 226M 9.66B | 405M 59.9M 52.06M 48.61M 44.62M 84.14M 5.71B 85.6M 573M 224M 2.85B 225M 220M 9.39B |
| Net income | -68.85M -10.19M -8.86M -8.27M -7.59M -14.31M -971M -14.56M -97.5M -38.19M -484M -38.28M -37.43M -1.6B | 14.57M 2.16M 1.87M 1.75M 1.61M 3.03M 206M 3.08M 20.63M 8.08M 103M 8.1M 7.92M 338M |
| Net Debt | -1.57B -233M -202M -189M -173M -327M -22.17B -332M -2.23B -872M -11.06B -874M -854M -36.47B | -1.54B -228M -198M -185M -170M -321M -21.76B -326M -2.18B -855M -10.85B -857M -838M -35.79B |
Employees
489
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-03 | CN¥8.900 | +1.14% | 4,687,800 |
| 26-07-31 | CN¥8.800 | +3.29% | 6,649,600 |
| 26-07-30 | CN¥8.520 | -3.18% | 8,246,013 |
| 26-07-29 | CN¥8.800 | -0.68% | 7,246,431 |
| 26-07-28 | CN¥8.860 | -1.23% | 6,108,200 |
- Stock Market
- Stocks
- 300485 Stock
Select your edition
All financial news and data tailored to specific country editions
